Results of in vitro experiments indicated that COX4 is implicated in the regulation of energy homeostasis in MTC-derived cells and suggested that evaluation of mitochondrial metabolic markers in tumor samples could prove useful for selection of therapeutic strategies in patients with medullary thyroid cancer. This evidence concerns the gene COX4I1 and medullary thyroid gland carcinoma.